GlassScriptPhysician profile
Beth Anne Perry
NPI 1891722872
$1,377.78
in general payments reported to CMS, 2019-2025
11 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $55.14 · 2023: $349 · 2024: $334 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $709.61 | 2023-2025 | |
| Almirall LLC | $143.18 | 2021-2025 | Klisyri, Seysara |
| Ucb, INC. | $125.01 | 2025 | Bimzelx |
| Galderma Laboratories, L.P. | $112.90 | 2021-2025 | Dysport |
| Sun Pharmaceutical Industries INC. | $66.43 | 2021-2024 | |
| Pfizer INC. | $57.41 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $42.08 | 2022-2025 | |
| Incyte Corporation | $41.77 | 2024-2025 | Opzelura |
| Genzyme Corporation | $29.82 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $29.60 | 2024 | Dupixent |
| Amgen INC. | $19.97 | 2025 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.